As a new type of foreign trade service provider driven by both technological transformation and foreign trade services, HiSiaddi has established a "1+2+3+4=1" service system and can supply raw materials from well-known original manufacturers of polygonum cuspidatum extract. With over a decade of market experience and technological transformation cooperation with factories, HiSiaddi boasts rich expertise in addressing product compliance issues. The following is HiSiaddi’s case handling compliance problems of polygonum cuspidatum extract.
If you need consultation on more compliance issues related to polygonum cuspidatum extract products, please contact HiSiaddi customer service.
The purchaser is BIOVITAL, a high-end biopharmaceutical company headquartered in Lyon, France. With 23 years of R&D and production experience in Western European medical aesthetic repair essences and hospital-grade oral anti-aging dietary supplements, its products are sold at premium medical aesthetic chains in Paris and organic pharmacies along the France-Switzerland border. All product lines comply with six major compliance systems: EU REACH Regulation, EC396 Pesticide Residues Directive, European Pharmacopoeia EP, French ANSES national food safety control, EU CPNP cosmetic raw material notification, as well as dual KOSHER & NON-GMO certifications. Positioned as a mid-to-high-end European medical aesthetic raw material buyer, the group rejects low-grade untraceable bulk extracts. Polygonum cuspidatum extract serves as the core formulation raw material for its oral anti-aging capsules and topical medical aesthetic repair essences. For many years prior, it sourced raw materials exclusively from established Italian plant extract manufacturers.
Driven by surging prices of native European raw materials and extended delivery lead times up to 95 days, the client launched a localized Chinese raw material procurement initiative. It independently selected two domestic polygonum cuspidatum extract factories and placed an initial order of 6.2 tons, including 10% compound polygonum cuspidatum extract and 98% high-purity resveratrol monomer. Upon sea freight arrival at Le Havre Port in France, the goods were detained for inspection by French Customs and ANSES food and drug authorities due to three major compliance violations: lack of EU Only Representative registration under REACH, partial pesticide residues exceeding EC396 limits, missing full GACP planting traceability files, and failure to complete EU CPNP cosmetic raw material notification for medical aesthetic-grade raw materials. Customs issued a detention and rectification notice, barring the goods from customs clearance and warehousing. Daily detention, storage and container detention fees exceeded EUR 3,200, halting the scheduled new product launch. If complete compliance documentation could not be submitted within the time limit, the entire container would be returned to origin or destroyed, with preliminary direct economic losses estimated at over EUR 120,000.
The two domestic suppliers could only provide domestic standard factory inspection reports and lacked practical experience in EU compliance, making them unable to fully supplement REACH registration, overseas filing and pesticide residue rectification documentation. The factories were only capable of adjusting product indicators, with no familiarity with French import drug declaration rules. Recommended by France’s Natural Raw Materials Industry Association, the client fully entrusted HiSiaddi, a foreign trade team with over ten years of experience in plant extract export compliance, to resolve all compliance challenges in one stop, covering registration filing, product rectification, document supplementation and customs appeal.
Mandatory legal compliance requirements stipulated by the client:
1. Pharmaceutical and dietary raw materials: Complete REACH registration corresponding to annual tonnage, SVHC Substances of Very High Concern screening reports, and designated EU Only Representative (OR);
2. Pesticide residues: 234 pesticide residue items compliant with EU Regulation EC396/2005, 70 pharmacopoeia-restricted pesticides within limits, with a detection limit ≤0.01mg/kg for unlisted pesticides;
3. Traceability: Complete GACP standardized planting compliance files covering the full chain of polygonum cuspidatum raw materials from cultivation and harvesting to processing, including soil and irrigation water test reports;
4. Topical medical aesthetic raw materials: Complete EU CPNP cosmetic raw material notification filing and issue SCCS safety assessment reports.
HiSiaddi’s compliance specialists immediately liaised with French Customs inspectors and ANSES reviewers, retrieved samples of detained goods and full original manufacturer documents, and decomposed four fatal compliance defects one by one, which are also the most common blind spots for domestic small and medium plant extract enterprises exporting to mid-to-high-end EU markets.
The two domestic suppliers only knew the name REACH but failed to complete corresponding substance registration based on the client’s annual procurement tonnage. Polygonum cuspidatum extract falls under UVCB multi-component natural extracts, and REACH registration requires tiered filing by annual export tonnage. The client’s annual procurement volume exceeds 12 tons, corresponding to the 10–100 ton registration tier, which requires full physicochemical data and basic toxicology test reports. EU regulations mandate non-EU manufacturers to appoint local EU enterprises as Only Representatives (OR), as importers cannot independently handle declaration. The absence of OR filing documents constituted the primary reason for customs detention. The manufacturers could only provide simplified MSDS drafted in accordance with domestic chemical industry standards, whose labeling and hazard classification failed to comply with EU CLP chemical classification regulations and could not be used for French import declarations.
Raw materials were sourced from scattered individual farmers’ polygonum cuspidatum rhizome harvests without standardized pesticide application ledgers from growers. Factory outgoing testing only covered over 20 conventional pesticide residues specified in Chinese Pharmacopoeia, omitting full 234-item screening required by the EU. Third-party laboratory retesting commissioned by French Customs found three types of organophosphorus pesticide residues exceeding limits, including one herbicide detected at 0.032mg/kg against the EU limit of 0.01mg/kg, plus five unlisted pesticides with no supporting test data, failing to meet ANSES entry inspection standards for France. Standard domestic COA reports followed testing methods and formats set by the Chinese Pharmacopoeia and were inadmissible by French drug authorities.
EU drug authorities mandate complete GACP standardized planting management archives for medicinal plant raw materials, including planting base geographic records, annual soil heavy metal and pesticide residue background testing reports, annual fertilization and pesticide application logs, harvesting and processing records, and batch traceability coding cross-references. The manufacturers sourced raw materials dispersedly from individual farmers in Sichuan and Hubei without standardized self-owned GAP planting bases, making it impossible to provide full documentation including land registration, soil environmental impact assessments and farmer pesticide application ledgers. ANSES could not confirm controllable pollutant risks for the raw materials and rejected import filing.
Half of the client’s 98% high-purity resveratrol monomer was used for medical aesthetic essence production. EU regulations require all cosmetic raw materials to be declared and entered into the EU CPNP cosmetic notification system prior to market launch to obtain exclusive notification codes. Neither the manufacturers nor the client completed this mandatory filing in advance, and raw materials without notification codes were prohibited from entering France’s cosmetic production lines.
HiSiaddi urgently assembled a special task force consisting of REACH compliance specialists, plant extract quality control engineers, EU regulatory declaration officers and third-party laboratory coordinators, and formulated a 45-day closed-loop rectification schedule divided into four phases: document supplementation, product rectification, overseas declaration and customs appeal.
1. HiSiaddi screened a Lyon-based local French institution with official REACH Only Representative qualifications and completed signing and filing on the same day. The institution was formally appointed as the EU OR on behalf of the domestic manufacturers. Enterprise and product basic information was entered into the ECHA European Chemicals Agency system, and OR authorization documents and institutional qualification certificates were submitted to French Customs to complete primary compliance filing with ECHA.
2. Coordinate CNAS-accredited third-party laboratories with GLP qualifications to supplement physicochemical parameters, skin irritation and mutagenicity basic toxicology tests for polygonum cuspidatum extract in line with REACH’s 10–100 ton tier testing requirements. Full registration technical dossiers were completed within 30 days to upgrade preliminary registration, with official pre-registration receipts issued.
3. Revise MSDS safety data sheets and bilingual English COA full inspection reports in full compliance with EU CLP rules; all labeling items, hazard warnings and ingredient classifications fully match French Customs declaration formats.
1. Eliminate original scattered farmer supply sources; HiSiaddi partnered with two mid-to-high-end factories with standardized GACP polygonum cuspidatum planting bases to source raw materials exclusively from standardized cultivation sites that can fully provide annual soil and irrigation water testing reports and field pesticide application ledgers, controlling pesticide residue risks from the source.
2. For the detained 6.2 tons of goods in transit, coordinate factories to conduct deep processing via activated carbon adsorption and secondary resin refining to remove pesticide residues. Post-processing samples were sent to authoritative third-party laboratories for full 234-item pesticide residue screening under EC396 standards; retesting confirmed all indicators compliant, with EU-recognized full English test reports issued.
3. Establish a batch traceability coding system, with each batch code linked to planting plots, harvest dates, processing teams and test order numbers to realize full one-item-one-code traceability.
HiSiaddi coordinated planting bases to sort out three years of full planting documentation: base land registration files, annual soil heavy metal & pesticide residue background monitoring reports, field plant protection pesticide application records, harvesting and processing workshop control records, and raw material inbound and outbound ledgers. All materials were translated into French and filed in accordance with official ANSES requirements, supplemented with on-site base photos and workshop quality control system audit materials to complete drug administration traceability document review and filing.
Sort out high-purity monomer physicochemical indicators, SCCS safety assessment reports and raw material toxicology summaries. HiSiaddi’s compliance specialists completed online information submission on the official EU CPNP system for medical aesthetic-grade resveratrol monomer to obtain an exclusive EU official notification number, and submitted the notification receipt to French drug authorities to complete supplementary access compliance certificates for medical aesthetic raw materials.
The full compliance rectification took 42 days, and all documents passed dual reviews by French Customs and ANSES. The detained 6.2 tons of polygonum cuspidatum extract successfully completed customs clearance and warehousing at the client’s French production plant. After raw material commissioning, the two production lines for oral capsules and medical aesthetic essences operated smoothly, and the delayed autumn and winter new product range was launched on schedule across all French medical aesthetic institutions and chain pharmacies.
Based on this complete end-to-end compliance delivery service, BIOVITAL immediately signed an annual long-term framework procurement contract for 22 tons, split into 13 tons of 10% compound extract and 9 tons of 98% high-purity monomer, delivered in 11 monthly batches throughout the year. HiSiaddi conducted pre-inspection of compliance documents and full compliance testing for all batches prior to shipment to fundamentally avoid future customs detention risks. The client later expanded its market into Spain and Belgium and placed new procurement orders for organic-certified customized raw polygonum cuspidatum extract, with HiSiaddi coordinating full-process application for EU organic certification to support the client’s organic raw material import compliance.
The following year, endorsed by this fixed-supply partnership with France’s leading medical aesthetic brand, the two cooperating mid-to-high-end polygonum cuspidatum extract manufacturers supported by HiSiaddi upgraded their internal compliance systems, completing full qualifications including REACH pre-registration, GACP planting bases and CPNP declaration. They successively secured long-term raw material orders from three equivalent mid-to-high-end medical aesthetic pharmaceutical enterprises in Spain and Switzerland, shifting away from the low-price homogenized raw material competition track to focus on high-end compliance-focused plant extract business. Building on this case, HiSiaddi refined a polygonum cuspidatum extract EU compliance database detailing country-specific access rules for France, Germany, the Netherlands and other EU member states, forming a standardized one-stop compliance service system covering upstream raw material quality control, document drafting, overseas declaration and customs appeal backstopping.
The vast majority of domestic plant extract manufacturers set product standards aligned with China’s national pharmacopoeia, lacking familiarity with segmented national regulations across the EU. Production lines only monitor active ingredient content while ignoring mandatory access compliance clauses including REACH registration, EC396 pesticide residues, GACP traceability and CPNP notification. While mid-to-high-end overseas pharmaceutical and medical aesthetic brands master stringent domestic drug administration regulations, they lack knowledge of China’s raw material cultivation models, domestic testing standards and compliance declaration workflows. Independent direct procurement easily leads to port detention, full-container return and substantial financial losses.
Breaking the traditional foreign trade model limited to simple intermediary supply of goods, HiSiaddi operates as a third-party compliance service provider, delivering end-to-end full-chain services covering front-end raw material compliance quality control, midstream document drafting and declaration, and back-end customs appeal backstopping. It bridges the compliance information gap arising from divergent Chinese and foreign regulatory standards, enabling mid-to-high-end overseas clients to safely implement localized Chinese raw material procurement while driving domestic premium plant extract manufacturers to establish international compliant production systems and steadily penetrate mid-to-high-end European natural raw material supply chains.
If you need consultation on more compliance issues related to polygonum cuspidatum extract products, please contact HiSiaddi customer service.
+86-13120989737 
info@hisiaddi.com 
English
